Acorn Bioventures, L.P. - Insider Trading & Ownership

Entity
Company
Location
295 Madison Avenue, 32 Nd Fl, New York, NY
Summary
The estimated value of insider holdings of Acorn Bioventures, L.P. is at least $3.85M dollars as of October 9, 2024. Acorn Bioventures, L.P. is the 10%+ Owner of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $3.85M.
All Insider Reports
All Insider Reports

Ownership of Acorn Bioventures, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OKUR OnKure Therapeutics, Inc. 10%+ Owner $3.85M Oct 4, 2024

There are no insider transactions reported by Acorn Bioventures, L.P.